Company

Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals develops cancer therapeutics.

About

Founded in 1987 and based in South San Francisco, Sunesis Pharmaceuticals focused on discovering and developing cancer treatments. The company went public in September 2005, raising USD 42 million by selling 6 million shares at USD 7 per share. It reported revenue of USD 120,000 and EBITDA of USD -22,268,000 in its most recent fiscal year.

2Funding rounds

9Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in